• 1
    Freeman JM, Vining EPG, Pillas DJ, et al. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998;102: 135863.
  • 2
    Vining EPG, Freeman JM, Ballaban-Gil K, et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 1998;55: 14337.
  • 3
    Keith HM. Factors influencing experimentally produced convulsions. Arch Neurol Psychol 1933;29: 14854.
  • 4
    Rho JM, White HS, Anderson G, et al. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-β-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002;43: 35861.
  • 5
    Likhodii S, Burnham M. Ketogenic diet: does acetone stop seizures? Med Sci Monit 2002;8: HY1924.
  • 6
    Thio LL, Wong M, Yamada KA. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 2000;54: 32531.
  • 7
    Donevan SD, Rogawski MA. Multiple actions of arylalkylamine arthropod toxins on the N-methyl-d-aspartate receptor. Neuroscience 1996;70: 36275.
  • 8
    Huttenlocher PR. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10: 53640.
  • 9
    Gilbert DL, Pyzik PL, Freeman JM. The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 2000;15: 78790.
  • 10
    Stafstrom CE. Animal models of the ketogenic diet: what have we learned, what can we learn? Epilepsy Res 1999;37: 24159.
  • 11
    Seymour KJ, Bluml S, Sutherling J, et al. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. MAGMA 1999;8: 3342.
  • 12
    Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1995;36(suppl 2):S212.
  • 13
    Meldrum BS. Update on the mechanism of action of antiepileptic drugs. Epilepsia 1996;37(suppl 6):S411.
  • 14
    Rho JM, Sankar R. The pharmacological basis of antiepileptic drug action. Epilepsia 1999;40: 147183.
  • 15
    Johnston GAR. GABA chemistry: analogs of GABA as therapeutic and investigational agents. In: MartinDL, OlsenRW, eds. GABA in the nervous system: the view at fifty years. Philadelphia : Lippincott Williams & Wilkins, 2000: 65.
  • 16
    Lustig S, Niesen CE. β-Hydroxybutyrate suppresses pentylenetetrazol (PTZ)-induced seizures in young adult rats. Epilepsia 1998;39(suppl 6):36.
  • 17
    Niesen CE, Ge S. The effect of ketone bodies, β-hydroxybutyrate and acetoacetate on acute seizure activity in hippocampal CA1 neurons. Epilepsia 1998;39(suppl 6):35.
  • 18
    Ge S, Niesen CE. β-Hydroxybutyrate potentiates GABAA-mediated inhibitory postsynaptic potentials in immature hippocampal CA1 neurons. Epilepsia 1998;39(suppl 6):135.
  • 19
    Laurie DJ, Wisden W, Seeburg PH. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain, III: embryonic and postnatal development. J Neurosci 1992;12: 415172.
  • 20
    Wisden W, Laurie DJ, Monyer H, et al. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain, I: telencephalon, diencephalon, mesencephalon. J Neurosci 1992;12: 104062.
  • 21
    Doepner B, Thierfelder S, Hirche H, et al. 3-Hydroxybutyrate blocks the transient K+ outward current in myocardial mouse cells in a stereoselective fashion. J Physiol (Lond) 1997;500: 8594.
  • 22
    Doepner B, Thierfelder S, Hirche H, et al. 3-Hydroxybutyrate blocks the transient K+ outward current in myocardial mouse cells in a stereoselective fashion. Retraction J Physiol (Lond) 1998;508: 956.
  • 23
    Doepner B, Koopmann R, Knopp A, et al. Dibenzylamine: a novel blocker of the voltage-dependent K+ current in myocardial mouse cells. Naunyn Schmiedebergs Arch Pharmacol 2001;364: 913.
  • 24
    Nakahiro M, Arakawa O, Narahashi T, et al. Dimethyl sulfoxide (DMSO) blocks GABA-induced current in rat dorsal root ganglion neurons. Neurosci Lett 1992;138: 58.
  • 25
    Lu C, Mattson MP. Dimethyl sulfoxide suppresses NMDA- and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons. Exp Neurol 2001;170: 1805.
  • 26
    Calvo MB, Pedraz JL, Dominguez-Gil A. Determination of low concentrations of dibenzylamine in human plasma and urine by gas chromatography with nitrogen-phosphorus detector. J Chromatogr 1989;490: 20612.
  • 27
    Fariello RG, Varasi M, Smith MC. Valproic acid: mechanisms of action. In: LevyRH, MattsonRH, MeldrumBS, eds. Antiepileptic drugs. 4th ed. New York : Raven Press, 1995: 581.
  • 28
    Yudkoff M, Daikhin Y, Nissim I, et al. Brain amino acid metabolism and ketosis. J Neurosci Res 2001;66: 27281.
  • 29
    Yudkoff M, Daikhin Y, Nissim I, et al. Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res 2001;66: 93140.
  • 30
    Veech RL, Chance B, Kashiwaya Y, et al. Ketone bodies, potential therapeutic uses. IUBMB Life 2001;51: 2417.